Advanced search
Publication Cover
Journal of Musculoskeletal Pain Volume 16, 2008 - Issue 3
Journal homepage
47
Views
6
CrossRef citations to date
0
Altmetric
CASE STUDIES

Use of Atomoxetine in a Patient with Fibromyalgia Syndrome and Attention-Deficit Hyperactivity Disorder

Yakov Vorobeychik Penn State Milton S. Hershey Medical Center, Penn State College of MedicineCorrespondence[email protected]
, MD, PhD &
Martin A. Acquadro Caritas Carney Hospital, Tufts University School of Medicine
, MD, DMD
Pages 189-192 | Received 15 Feb 2007, Accepted 26 Apr 2007, Published online: 10 Jul 2009

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ertan Yılmaz & Lut Tamam. (2018) Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatric Disease and Treatment 14, pages 1883-1889.
Read now

Articles from other publishers (5)

Satoshi Kasahara, Miwako Takahashi, Taito Morita, Ko Matsudaira, Naoko Sato, Toshimitsu Momose, Shin-Ichi Niwa & Kanji Uchida. (2023) Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder. Frontiers in Psychiatry 14.
Crossref
Satoshi Kasahara, Yuichi Kato, Miwako Takahashi, Ko Matsudaira, Naoko Sato, Shin-Ichi Niwa, Toshimitsu Momose & Kanji Uchida. (2023) Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole. Frontiers in Pain Research 4.
Crossref
Wahiba Sifeddine, Saadia Ba-M’hamed, Marc Landry & Mohamed Bennis. (2023) Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice. Pharmacological Reports 75:2, pages 342-357.
Crossref
Ekachaeryanti Zain, Atsunori Sugimoto, Jun Egawa & Toshiyuki Someya. (2023) Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder. Frontiers in Psychiatry 14.
Crossref
Michael Webster. (2015) Pharmacologic basis for the use of selective norepinephrine reuptake inhibitors for the treatment of neuropathic pain conditions. Mental Health Clinician 5:6, pages 284-288.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.